We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+0.5%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$13.5B
AUM Growth
-$613M
(-4.3%)
Cap. Flow
-$587M
Cap. Flow
% of AUM
-4.35%
Top 10 Holdings %
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
203
Reduced
624
Closed
38
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
MPLX
MPLX
|
+$30.1M |
| 2 |
Energy Transfer Partners
ET
|
+$24.7M |
| 3 |
Franklin FTSE Japan ETF
FLJP
|
+$11.8M |
| 4 |
Wells Fargo
WFC
|
+$9.66M |
| 5 |
Alkermes
ALKS
|
+$8.97M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$49.8M |
| 2 |
Enterprise Products Partners
EPD
|
+$49.1M |
| 3 |
Western Midstream Partners
WES
|
+$44.8M |
| 4 |
BPL
Buckeye Partners, L.P.
BPL
|
+$42.5M |
| 5 |
EQM
EQM Midstream Partners, LP
EQM
|
+$28.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 65.41% |
| 2 | Financials | 7.05% |
| 3 | Healthcare | 3.6% |
| 4 | Consumer Discretionary | 3.1% |
| 5 | Technology | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Halozyme
HALO
$9.72B
| $5.21M | 0.04% |
303,357
-46,953
| -13% | -$758K |
|
152
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.1B
| $5.19M | 0.04% |
105,273
+1,299
| +1% | +$63.6K |
|
153
Emergent Biosolutions
EBS
$375M
| $5.18M | 0.04% |
107,161
-16,506
| -13% | -$791K |
|
|
SAND
154
DELISTED
Sandstorm Gold
SAND
| $5.07M | 0.04% |
915,228
+211,548
| +30% | +$1.14M |
|
155
Ligand Pharmaceuticals
LGND
$6.02B
| $5.05M | 0.04% |
70,904
-13,954
| -16% | -$1.03M |
|
156
ExxonMobil
XOM
$651B
| $4.92M | 0.04% |
64,192
-828
| -1% | -$64.1K |
|
157
Alphabet (Google) Class A
GOOGL
$3.91T
| $4.62M | 0.03% |
85,260
-5,040
| -6% | -$292K |
|
158
Boeing
BA
$165B
| $4.59M | 0.03% |
12,617
+217
| +2% | +$79.1K |
|
159
Gold Fields
GFI
$29.2B
| $4.58M | 0.03% |
846,122
-398
| -0% | -$1.7K |
|
|
AKCA
160
DELISTED
Akcea Therapeutics Inc
AKCA
| $4.54M | 0.03% |
+193,375
| New | +$4.78M |
|
|
XLRN
161
DELISTED
Acceleron Pharma
XLRN
| $4.51M | 0.03% |
109,832
-14,654
| -12% | -$607K |
|
162
Bank of America
BAC
$435B
| $4.48M | 0.03% |
154,516
-42,548
| -22% | -$1.23M |
|
163
Home Depot
HD
$332B
| $4.46M | 0.03% |
21,469
-3,187
| -13% | -$636K |
|
|
164
Alphabet (Google) Class C
GOOG
$3.9T
| $4.32M | 0.03% |
79,900
-4,400
| -5% | -$254K |
|
165
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$9.46B
| $4.13M | 0.03% |
143,603
+2,147
| +2% | +$60.1K |
|
166
First Solar
FSLR
$21.8B
| $4.12M | 0.03% |
62,684
+23,361
| +59% | +$1.41M |
|
|
XIFR
167
XPLR Infrastructure LP
XIFR
$1.18B
| $4.07M | 0.03% |
84,355
+36,764
| +77% | +$1.7M |
|
|
ALLK
168
DELISTED
Allakos
ALLK
| $3.89M | 0.03% |
+89,860
| New | +$3.69M |
|
169
Acuity Brands
AYI
$9.88B
| $3.79M | 0.03% |
27,516
+12,754
| +86% | +$1.75M |
|
170
Harmony Gold Mining
HMY
$9.92B
| $3.79M | 0.03% |
1,669,983
-77,962
| -4% | -$144K |
|
171
Enanta Pharmaceuticals
ENTA
$372M
| $3.77M | 0.03% |
44,686
-6,184
| -12% | -$556K |
|
172
Vanguard Small-Cap ETF
VB
$79.5B
| $3.75M | 0.03% |
23,937
-304
| -1% | -$47K |
|
173
Universal Display
OLED
$3.71B
| $3.74M | 0.03% |
19,867
+9,722
| +96% | +$1.62M |
|
174
Eli Lilly
LLY
$1.07T
| $3.6M | 0.03% |
32,515
+1,035
| +3% | +$122K |
|
175
Broadcom
AVGO
$1.82T
| $3.6M | 0.03% |
125,060
-12,780
| -9% | -$372K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2019 Portfolio in Review
As of Q2 2019, ALPS Advisors held 914 positions worth $13.5B, down 4.3% from $14.1B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
ALPS Advisors withdrew a net $587M in Q2 2019, closing 38 positions and reducing 624 holdings. Its most notable exit was Lakefront Biotherapeutics American Depositary Shares, an estimated $10.3M position sold in full.
By sector, the portfolio is most concentrated in Energy at 65% of assets, down from 66% a quarter earlier, followed by Financials and Healthcare.
Against the trend, ALPS Advisors opened a new position in Franklin FTSE Japan ETF worth $11.8M.
- ALPS Advisors's largest Q2 2019 buy was Franklin FTSE Japan ETF: 491,070 shares worth $11.8M.
- ALPS Advisors added most to MPLX in Q2 2019, an estimated $30.1M increase.
- ALPS Advisors's biggest Q2 2019 reduction was Magellan Midstream Partners, L.P., cutting an estimated $49.8M.
- ALPS Advisors fully exited Lakefront Biotherapeutics American Depositary Shares in Q2 2019, selling an estimated $10.3M.
- ALPS Advisors's ten largest holdings make up 48% of its $13.5B portfolio in Q2 2019.
- ALPS Advisors opened 36 new positions and closed 38 in Q2 2019.
- ALPS Advisors's portfolio value fell 4.3% quarter-over-quarter to $13.5B.
Based on ALPS Advisors's 13F filing for Q2 2019, filed 7 Aug 2019.